GlassScriptPhysician profile
Elaine Ho
NPI 1134738040
$1,569.62
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $789 · 2022: $780.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $438.11 | 2021-2022 | |
| Novo Nordisk INC | $175.65 | 2022 | |
| Glaxosmithkline, LLC. | $152.58 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.40 | 2021-2022 | |
| Lilly USA, LLC | $88.30 | 2021 | |
| Indivior INC. | $75.19 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $70.34 | 2022 | |
| Collegium Pharmaceutical, INC. | $67.69 | 2021 | |
| Astellas Pharma US INC | $62.88 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.27 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $27.30 | 2021 | |
| Alkermes, INC. | $24.00 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.07 | 2022 | |
| Eisai INC. | $22.26 | 2021 | |
| Genzyme Corporation | $22.22 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $20.15 | 2021 | |
| Xeris Pharmaceuticals, INC. | $19.87 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $19.62 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.69 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.65 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $15.02 | 2021 | |
| Amgen INC. | $14.73 | 2021 | |
| Neurocrine Biosciences, INC. | $14.00 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.88 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.75 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elaine Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.